SCHEMBL30762659

SCHEMBL30762659

Cc1ccc2nc(N3CCOCC3)ccc2c1C#N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.51
▸ HPGD P15428 6/20 0.51
▸ KDM4E B2RXH2 5/20 0.51
▸ GAA P10253 3/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ HTT P42858 3/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ ATM Q13315 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ CYP1A2 P05177 2/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ GLA P06280 1/20 0.49
▸ TSHR P16473 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ CASP1 P29466 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12701772 0.81 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL30762625 0.78 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL30762528 0.78 KMT2A (0.55) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL30762666 0.74 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL17531163 0.72 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL14573270 0.72 ALDH1A1 (0.47) ALDH1A1HPGDKDM4ESMN1; SMN2HTT
SCHEMBL29193671 0.71 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EGAAHTT
SCHEMBL11753128 0.70 ALDH1A1 (0.76) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL24195087 0.69 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL4658327 0.69 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026423-A1 SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback